STOCKHOLDERS’ EQUITY AND NONCONTROLLING INTERESTS

Share Repurchase Program

In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase (“ASR”) programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of June 29, 2018, approximately 4.1 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.

The Company repurchased shares of VMS common stock under various authorizations during the periods presented as follows:



	Three Months Ended				Nine Months Ended
(In millions, except per share amounts)	June 29, 2018		June 30, 2017		June 29, 2018		June 30, 2017
Number of shares	0.3		0.5		1.1		3.0
Average repurchase price per share	$	120.59	$	93.45	$	112.25	$	89.68
Total cost	$	39.2	$	46.8	$	131.9	$	269.1

Other Comprehensive Earnings

The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:



(In millions)	Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans			Net Unrealized Gains (Losses) Cash Flow Hedging Instruments			Cumulative Translation Adjustment			Accumulated Other Comprehensive Loss
Balance at September 29, 2017	$	(44.1	)	$	—		$	(24.7	)	$	(68.8	)
Other comprehensive earnings (loss) before reclassifications	—			(0.9		)	(3.0		)	(3.9		)
Amounts reclassified out of other comprehensive earnings (loss)	1.3			0.9			—			2.2
Tax expense	(0.2		)	—			—			(0.2		)
Balance at June 29, 2018	$	(43.0	)	$	—		$	(27.7	)	$	(70.7	)



(In millions)	Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans			Cumulative Translation Adjustment			Accumulated Other Comprehensive Loss
Balance at September 30, 2016	$	(63.3	)	$	(37.5	)	$	(100.8	)
Other comprehensive loss before reclassifications	—			4.5			4.5
Amounts reclassified out of other comprehensive earnings (loss)	2.8			—			2.8
Tax expense	(0.5		)	—			(0.5		)
Balance at June 30, 2017	$	(61.0	)	$	(33.0	)	$	(94.0	)

The amounts reclassified out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows:



	Three Months Ended						Nine Months Ended
(In millions)	June 29, 2018			June 30, 2017			June 29, 2018			June 30, 2017
Comprehensive Earnings Components	Loss Before Taxes						Loss Before Taxes						Line Item in Statements of Earnings
Unrealized loss on defined benefit pension and post-retirement benefit plans	$	(0.4	)	$	(0.9	)	$	(1.3	)	$	(2.8	)	Cost of revenues & Operating expenses
Unrealized loss on cash flow hedging instruments	—			—			(0.9		)	—			Revenues
Total amounts reclassified out of other comprehensive earnings (loss)	$	(0.4	)	$	(0.9	)	$	(2.2	)	$	(2.8	)

Noncontrolling Interests

In connection with the Distribution of Varex in January 2017, the Company's redeemable noncontrolling interests relating to MeVis Medical Solutions AG ("MeVis") were transferred to Varex.

Changes in noncontrolling interests and redeemable noncontrolling interests relating to MeVis and other subsidiaries of the Company were as follows:



	Nine Months Ended
	June 29, 2018		June 30, 2017
(In millions)	Noncontrolling Interests		Noncontrolling Interests		Redeemable Noncontrolling Interests
Beginning of Period	$	4.3	$	3.7	$	10.3
Net earnings attributable to noncontrolling interests	—		0.6		0.1
Transfer of redeemable noncontrolling interests in MeVis to Varex	—		—		(10.3		)
Other	—		—		(0.1		)
End of Period	$	4.3	$	4.3	$	—